Programa / Programme
Chairs
|
|
|
|
|
| Professor Derek Yellon |
Professor Andrei Sposito |
Professor Otávio Coelho |
Professor Antonio Chagas |
| The Hatter Cardiovascular Institute University College London, UK |
State University of Campinas Medicine School of Brazil |
State University of Campinas Medicine School of Brazil |
University of São Paulo Heart Institute São Paulo, Brazil |
|
|
 |
|
|
| Professor John Cunningham |
Dr Peter Libby |
Dr Marc Pfeffer |
Professor Brian Rayner |
| UCL Medical School & The Royal Free Hospital, UK |
Brigham and Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA |
Brigham and Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA |
University of Cape Town Cape Town, South Africa |
| Thursday, 21 October 2021 | |
| 8:30 am | Registration & badge collection |
| 9:30 am |
Welcome to the event. The Chairs |
|
PolyPill or Precision Medicine – is there room for both? Borja Ibanez CNIC, Madrid, Spain |
|
|
The conditioning phenomenon – have we reached the limits? Professor Derek Yellon University College London, UK |
|
| Break | |
|
New strategies to mitigate the residual vascular risk in diabetes. Professor Alberto Lorenzatti Fundación Rusculleda, Córdoba, Argentina |
|
| Industry Satellite Symposium | |
| 1:35 pm | Lunch |
| 2:35 pm |
Heart failure at the limits – have we achieved appropriate therapy at last! Professor Marco Metra University of Brescia, Italy |
|
Can we prevent today’s cancer patient from being tomorrow’s heart failure patient? Dr Malcolm Walker University College London, UK |
|
|
Management of anemia in chronic kidney disease: time to challenge the limits? Professor Roberto Pecoits Ann Arbor, Michigan, USA |
|
| 4:35 pm | Close |
| Friday, 22 October 2021 | |
| 9:00 am | Industry Satellite Symposium |
|
HIV as a cardiovascular risk factor. Professor Mpiko Ntsekhe University of Cape Town, South Africa |
|
| Break | |
|
Understanding and treating systemic vasculitis. Where are the limits? Professor Alan Salama Centre for Nephrology, UCL, London |
|
|
GLP-1 analogues – modern treatment for type 2 diabetes. Professor Niko Marx University of Aachen, Germany |
|
| 12:45 pm | Lunch |
| 1:45 |
Three decades of changes in the burden of cardiovascular disease in Latin America. Professor Paulo Lotufo University of São Paulo, Brazil |
|
Fact and Fiction in Mesoamerican Nephropathy – what do we know? Professor Rick Johnson University of Colorado, USA |
|
|
Closing remarks. The Chairs |
|
| 3:15 pm | Close and depart |
